Herpes zoster - Cudurka Herpes
☆ AI Dermatology — Free Service
Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
Herpes zoster: finanka qoorta iyo garabka
relevance score : -100.0%
ReferencesShingles, oo ay sababto dib-u-kicinta fayraska varicella zoster ee mas'uulka ka ah busbuska, wuxuu saameeyaa qiyaastii 1 milyan oo qof sanadkiiba gudaha Mareykanka, iyadoo khatarta dhimashada ay tahay 30%. Kuwa difaaca jidhkoodu daciif yahay aad bay ugu nugul yihiin inay yeeshaan shingles. Calaamadaha caadiga ah waxay ka bilaabmaan xanuun, madax‑xanuun, iyo qandho fudud, ka dibna waxaa la dareemaa maqaarka oo aan caadi ahayn dhowr maalmood ka hor muuqaalka finan. Finanka, oo badanaa ka soo baxa meel gaar ah oo jidhka ah, waxay noqdaan finan cad oo leh qolof nabarro ah, waxaana ay muuqdaan toddobaad gudihiis ilaa toban maalmood. Daaweynta degdega ah ee antiviral‑ka (acyclovir, valacyclovir, ama famciclovir) oo la bilaabo 72 saacadood gudahood ka dib marka ay bilaabmaan finan yaryar ayaa muhiim ah. Postherpetic neuralgia, oo ah xaalad caadi ah oo lagu garto xanuun daba dheeraada ee aagga ay dhibaatadu saameysay, waxay saamaysaa qiyaastii 10 % ee bukaanada, waxaana loo baahan yahay maarayn joogto ah oo ay ka mid yihiin dawooyinka sida gabapentin, pregabalin, ama antidepressants qaarkood, iyo sidoo kale wakiilada maxalliga ah sida lidocaine ama capsaicin. Tallaalka ka hortagga fayraska varicella zoster waxaa lagula talinayaa dadka waaweyn ee da'doodu tahay 50 sano ama ka weyn, si loo yareeyo khatarta shingles.
Shingles, caused by the reactivation of the varicella zoster virus responsible for chickenpox, affects around 1 million people annually in the United States, with a lifetime risk of 30%. Those with weakened immune systems are significantly more prone to developing shingles, with symptoms typically starting with malaise, headache, and a mild fever, followed by unusual skin sensations a few days before the appearance of a rash. This rash, usually appearing in a specific area of the body, progresses from clear blisters to crusted sores over a week to ten days. Prompt treatment with antiviral medications (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset is crucial. Postherpetic neuralgia, a common complication characterized by prolonged pain in the affected area, affects about one in five patients and requires ongoing management with medications such as gabapentin, pregabalin, or certain antidepressants, along with topical agents like lidocaine or capsaicin. Vaccination against the varicella zoster virus is recommended for adults aged 50 and above to reduce the risk of shingles.
Shingles, caused by the reactivation of the varicella zoster virus responsible for chickenpox, affects around 1 million people annually in the United States, with a lifetime risk of 30%. Those with weakened immune systems are significantly more prone to developing shingles, with symptoms typically starting with malaise, headache, and a mild fever, followed by unusual skin sensations a few days before the appearance of a rash. This rash, usually appearing in a specific area of the body, progresses from clear blisters to crusted sores over a week to ten days. Prompt treatment with antiviral medications (acyclovir, valacyclovir, or famciclovir) within 72 hours of rash onset is crucial. Postherpetic neuralgia, a common complication characterized by prolonged pain in the affected area, affects about one in five patients and requires ongoing management with medications such as gabapentin, pregabalin, or certain antidepressants, along with topical agents like lidocaine or capsaicin. Vaccination against the varicella zoster virus is recommended for adults aged 50 and above to reduce the risk of shingles.
Herpes zoster waxay inta badan ku dhacdaa dadka da'doodu tahay 50 sano iyo ka weyn, kuwa leh habka difaaca daciifka ah, iyo kuwa qaata daawooyinka immunosuppressive. Fayraska varicella‑zoster, oo ah isla fayraska keena busbuska, ayaa keena. Calaamadaha sida qandho, xanuun, iyo cuncun ayaa caadi ahaan ka horreeya muuqaalka finan gaarka ah. Dhibaatada ugu caansan waa neuralgia post‑herpetic, oo ah xanuunka neerfaha ee joogtada ah ka dib marka finan ay bogsadaan. Halista iyo dhibaatooyinka la xiriira zoster‑ka way kala duwan yihiin iyadoo ku xiran da'da, xaaladda difaaca, iyo waqtiga daaweynta la bilaabo. Talaalka shakhsiyaadka da'doodu tahay 60 iyo wixii ka sareeya ayaa la muujiyay inuu si weyn u yareynayo dhacdooyinka herpes zoster iyo post‑herpetic neuralgia. Bilowga daawooyinka ka hortagga fayraska iyo xanuun‑yareeyayaasha 72 saacadood gudahood ee finan yaryar ayaa yareyn kara darnaanta iyo dhibaatooyinka herpes zoster‑ka iyo neuralgia post‑herpetic.
Herpes zoster tends to occur more frequently in people aged 50 and older, those with weakened immune systems, and those taking immunosuppressant medications. It's triggered by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Symptoms like fever, pain, and itching commonly precede the appearance of the characteristic rash. The most common complication is post-herpetic neuralgia, which is persistent nerve pain after the rash clears up. The risk factors and complications associated with herpes zoster vary depending on age, immune health, and timing of treatment initiation. Vaccination for individuals aged 60 and above has been shown to significantly reduce the occurrence of herpes zoster and post-herpetic neuralgia. Starting antiviral medications and pain relievers within 72 hours of rash onset can lessen the severity and complications of herpes zoster and post-herpetic neuralgia.
Herpes zoster tends to occur more frequently in people aged 50 and older, those with weakened immune systems, and those taking immunosuppressant medications. It's triggered by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Symptoms like fever, pain, and itching commonly precede the appearance of the characteristic rash. The most common complication is post-herpetic neuralgia, which is persistent nerve pain after the rash clears up. The risk factors and complications associated with herpes zoster vary depending on age, immune health, and timing of treatment initiation. Vaccination for individuals aged 60 and above has been shown to significantly reduce the occurrence of herpes zoster and post-herpetic neuralgia. Starting antiviral medications and pain relievers within 72 hours of rash onset can lessen the severity and complications of herpes zoster and post-herpetic neuralgia.
Tijaabooyinka caafimaad ee ka hor ansixinta waxay muujinayaan in tallaalka zoster-ka nool uu shaqeeyo ku dhawaad 50% ilaa 70%, halka tallaalka dib-u-daawaynta uu si fiican u shaqeeyo, oo u dhexeeya 90% ilaa 97%. Daraasadaha dhabta ah ee adduunka waxay taageeraan natiijooyinka tijaabooyinka, iyagoo muujinaya in tallaalka nool uu waxtar u leeyahay qiyaastii 46%, halka tallaalka dib-u-dhiska uu yahay 85%.
The pre-licensure clinical trials show the efficacy of the live zoster vaccine to be between 50 and 70% and for the recombinant vaccine to be higher at 90 to 97%. Real-world effectiveness studies, with a follow-up of approximately 10 years, were reviewed in this article. These data corroborated the efficacy studies, with vaccine effectiveness being 46% and 85% for the live and recombinant vaccines, respectively.
The pre-licensure clinical trials show the efficacy of the live zoster vaccine to be between 50 and 70% and for the recombinant vaccine to be higher at 90 to 97%. Real-world effectiveness studies, with a follow-up of approximately 10 years, were reviewed in this article. These data corroborated the efficacy studies, with vaccine effectiveness being 46% and 85% for the live and recombinant vaccines, respectively.
Busbuska, oo sidoo kale loo yaqaan varicella, waa caabuq bilow ah oo ay keento fayraska, caadi ahaan inta lagu jiro carruurnimada ama qaan-gaarka. Marka busbuska uu bogsado, fayrasku wuxuu sii ahaan karaa mid aan firfircoonayn (hurdo) unugyada neerfaha bini’aadamka sanado ama tobanaan sano, ka dibna dib ayuu u kici karaa. Natiijadu waa in fayraska varicella ee hurda dib loo hawlgeliyo, taasoo keenta cudurka herpes (Herpes zoster). Fayrasku wuxuu ku faafaa neerfaha ilaa maqaarka, isagoo soo saara finan. Inta lagu jiro dillaaca cudurka herpes (Herpes zoster), fayraska varicella ee laga helo finanka wuxuu u keeni karaa qof aan weli qabin busbus inuu qaado busbus.
Waxyaabaha khatarta ah ee dib-u-kicinta fayraska hurda waxaa ka mid ah gabowga, difaac jidheed oo liita, iyo busbus hore oo dhacay ka hor 18 bilood jir. Fayraska Varicella‑zoster ma aha fayraska herpes simplex, in kasta oo labaduba ay ka tirsan yihiin qoyska herpes.
Tallaalada cudurka herpes (Herpes zoster) waxay yareeyaan halista cudurka 50% ilaa 90%. Waxay sidoo kale hoos u dhigaan heerka postherpetic neuralgia, iyo haddii cudurka dhaco, darnaantiisa. Haddii cudurka uu bilaabo, daawooyinka antiviral sida aciclovir waxay yareyn karaan darnaanta iyo muddada cudurka haddii la bilaabo 72 saacadood gudahood ka dib muuqaalka finanka.
○ Daawaynta
Haddii finanku ay si degdeg ah u faafaan, u tag dhakhtarkaaga sida ugu dhakhsaha badan si loo bilaabo daaweynta antiviral. Daawooyinka antiviral iyo kuwa neuralgia labadaba waa lagama maarmaan. Nasasho ku filan samee, kana fogaaw cabbitaanka khamriga.
#Acyclovir
#Fancyclovir
#Valacyclovir
#Gabapentin
#Pregabalin